Related Experiment Video
Updated: Sep 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular
Xiaolei Lin1, Chao Jiang2,3,4, Zhiyan Wang2,3,4
1Data Science, Fudan University, Shanghai, China.
Insights
The Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT) investigates if intensive blood pressure control (<120 mmHg) reduces cardiovascular events in atrial fibrillation patients compared to standard control (<135 mmHg). This study ensures transparent analysis through a pre-defined statistical plan.
Area of Science:
- Cardiology
- Clinical Trials
- Hypertension Management
Background:
- Elevated blood pressure (BP) is a significant risk factor for cardiovascular (CV) complications in patients with atrial fibrillation (AF).
- Current guidelines suggest moderate BP targets, but the optimal BP goal for AF patients remains unclear.
- The Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT) addresses this uncertainty.
Purpose of the Study:
- To evaluate if intensive home systolic BP control (<120 mmHg) is more effective than standard BP control (<135 mmHg) in reducing major CV events in AF patients.
- To compare the efficacy of two distinct BP management strategies in a high-risk population.
Main Methods:
- A multicenter, prospective, randomized, open-label, blinded-endpoint trial design.
- Enrollment of 1,675 participants to achieve 80% power for detecting a win ratio of 1.50.
- Primary outcome: hierarchical composite of CV death, stroke, myocardial infarction, and heart failure hospitalization.
Main Results:
- The primary outcome analysis will utilize the win-ratio method.
- Secondary outcomes will be analyzed using Cox proportional hazards and Poisson regression.
- Sensitivity analyses and missing data handling strategies are pre-specified.
Conclusions:
- A pre-defined Statistical Analysis Plan (SAP) ensures transparency and verifiability of the CRAFT trial results.
- The SAP was finalized prospectively, independent of treatment assignment, to maintain internal validity and minimize bias.
- This rigorous approach aims to provide reliable evidence on optimal BP management in AF.
Introduction:
Elevated blood pressure (BP) is a key modifiable risk factor for cardiovascular (CV) complications in patients with atrial fibrillation (AF). While current guidelines recommend modest BP targets, the optimal target in AF patients remains uncertain. The Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT) is a multicenter, prospective, randomized, open-label, blinded endpoint trial that evaluates whether intensive home systolic BP control (<120 mm Hg) is superior to standard BP control (<135 mm Hg) in reducing major CV events. The primary outcome is a hierarchical composite of time to CV death, stroke, myocardial infarction, and heart failure hospitalization. A total sample of 1,675 participants provides 80% power to detect a win ratio of 1.50 between groups after a mean of 3 years of follow-up.
Methods:
This statistical analysis plan (SAP) was developed by the trial statistician and principal investigators, in collaboration with the Steering Committee and international experts. The SAP specifies the planned analyses of baseline characteristics, patients' intervention, primary and secondary outcomes, subgroup effects, and safety outcomes. Analyses will be conducted on an intention-to-treat analysis using the win ratio method for the primary endpoint and Cox proportional hazards and Poisson regression for secondary analyses. Sensitivity analyses and strategies for handling missing data are also described.
Conclusion:
A predefined SAP was established for the CRAFT trial to ensure a transparent and verifiable analysis. The SAP was finalized prospectively, independent of treatment assignment, with the goal of preserving internal validity and minimizing analytical bias.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Atherosclerosis III: Management
Pre-Procedural Guidelines for Assessing Blood Pressure
Clinical Trials
There are four phases in a clinical trial. A phase one...
Venous Thrombosis III: Interprofessional Care
Errors occurring during blood pressure monitoring
Several factors...

